APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Vessel

Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.

The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.

Selected research

Market Outlook & Growth Opportunities

Global Artificial Blood Vessel Market Outlook and Growth Opportunities 2026

9 January 2026199 pages

Choose your research edition.

Industry ResearchArtificial Blood Vessel Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Vessel Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Artificial Blood Vessel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Vessel Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Vessel Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.

The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.

Asia-Pacific is the largest artificial blood vessel market with about 38% market share. North America is follower, accounting for about 30% market share.

Read the full market overview

The key players are Getinge, BD(Bard), Terumo etc. Top 1 company occupied about 45% market share.

This report provides an overview of the global Artificial Blood Vessel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Blood Vessel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Blood Vessel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Blood Vessel market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Blood Vessel Segment by Company

Getinge

BD (Bard)

Terumo

W. L. Gore

Japan Lifeline

B.Braun

LeMaitre Vascular

Suokang

Chest Medical

Artificial Blood Vessel Segment by Type

EPTFE

Polyethylene Terephthalate

Polyurethane

Others

Artificial Blood Vessel Segment by Application

Aortic Disease

Peripheral Artery Disease

Hemodialysis

Artificial Blood Vessel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Blood Vessel status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artificial Blood Vessel market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Blood Vessel significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Blood Vessel competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Vessel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Vessel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Vessel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Blood Vessel market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Blood Vessel industry.

Chapter 3: Detailed analysis of Artificial Blood Vessel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artificial Blood Vessel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artificial Blood Vessel in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Blood Vessel Industry Trends Table 2. Artificial Blood Vessel Industry Drivers Table 3. Artificial Blood Vessel Industry Opportunities and Challenges Table 4. Artificial Blood Vessel Industry Restraints Table 5. Global Artificial Blood Vessel Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Blood Vessel Revenue Share by Company (2021-2026) Table 7. Global Artificial Blood Vessel Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Artificial Blood Vessel Sales Volume Share by Company (2021-2026) Table 9. Global Artificial Blood Vessel Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Artificial Blood Vessel Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artificial Blood Vessel Key Company Manufacturing Base & Headquarters Table 12. Global Artificial Blood Vessel Company, Product Type & Application Table 13. Global Artificial Blood Vessel Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Blood Vessel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of EPTFE Table 18. Significant Companies of Polyethylene Terephthalate Table 19. Significant Companies of Polyurethane Table 20. Significant Companies of Others Table 21. Global Artificial Blood Vessel Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Artificial Blood Vessel Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Artificial Blood Vessel Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Artificial Blood Vessel Sales Volume Share by Type (2021-2026) Table 25. Global Artificial Blood Vessel Sales Volume Share by Type (2027-2032) Table 26. Global Artificial Blood Vessel Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Artificial Blood Vessel Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Artificial Blood Vessel Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Artificial Blood Vessel Sales Value Share by Type (2021-2026) Table 30. Global Artificial Blood Vessel Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Aortic Disease Table 32. Significant Companies of Peripheral Artery Disease Table 33. Significant Companies of Hemodialysis Table 34. Global Artificial Blood Vessel Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Artificial Blood Vessel Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Artificial Blood Vessel Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Artificial Blood Vessel Sales Volume Share by Application (2021-2026) Table 38. Global Artificial Blood Vessel Sales Volume Share by Application (2027-2032) Table 39. Global Artificial Blood Vessel Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Artificial Blood Vessel Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Artificial Blood Vessel Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Artificial Blood Vessel Sales Value Share by Application (2021-2026) Table 43. Global Artificial Blood Vessel Sales Value Share by Application (2027-2032) Table 44. Global Artificial Blood Vessel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Artificial Blood Vessel Sales by Region (2021-2026) & (K Units) Table 46. Global Artificial Blood Vessel Sales Market Share by Region (2021-2026) Table 47. Global Artificial Blood Vessel Sales by Region (2027-2032) & (K Units) Table 48. Global Artificial Blood Vessel Sales Market Share by Region (2027-2032) Table 49. Global Artificial Blood Vessel Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Artificial Blood Vessel Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Artificial Blood Vessel Sales Value Share by Region (2021-2026) Table 52. Global Artificial Blood Vessel Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Artificial Blood Vessel Sales Value Share by Region (2027-2032) Table 54. Global Artificial Blood Vessel Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Artificial Blood Vessel Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Artificial Blood Vessel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Artificial Blood Vessel Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Artificial Blood Vessel Sales by Country (2021-2026) & (K Units) Table 59. Global Artificial Blood Vessel Sales Market Share by Country (2021-2026) Table 60. Global Artificial Blood Vessel Sales by Country (2027-2032) & (K Units) Table 61. Global Artificial Blood Vessel Sales Market Share by Country (2027-2032) Table 62. Global Artificial Blood Vessel Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Artificial Blood Vessel Sales Value Market Share by Country (2021-2026) Table 64. Global Artificial Blood Vessel Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Artificial Blood Vessel Sales Value Market Share by Country (2027-2032) Table 66. Getinge Company Information Table 67. Getinge Business Overview Table 68. Getinge Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Getinge Artificial Blood Vessel Product Portfolio Table 70. Getinge Recent Development Table 71. BD (Bard) Company Information Table 72. BD (Bard) Business Overview Table 73. BD (Bard) Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. BD (Bard) Artificial Blood Vessel Product Portfolio Table 75. BD (Bard) Recent Development Table 76. Terumo Company Information Table 77. Terumo Business Overview Table 78. Terumo Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Terumo Artificial Blood Vessel Product Portfolio Table 80. Terumo Recent Development Table 81. W. L. Gore Company Information Table 82. W. L. Gore Business Overview Table 83. W. L. Gore Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. W. L. Gore Artificial Blood Vessel Product Portfolio Table 85. W. L. Gore Recent Development Table 86. Japan Lifeline Company Information Table 87. Japan Lifeline Business Overview Table 88. Japan Lifeline Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Japan Lifeline Artificial Blood Vessel Product Portfolio Table 90. Japan Lifeline Recent Development Table 91. B.Braun Company Information Table 92. B.Braun Business Overview Table 93. B.Braun Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. B.Braun Artificial Blood Vessel Product Portfolio Table 95. B.Braun Recent Development Table 96. LeMaitre Vascular Company Information Table 97. LeMaitre Vascular Business Overview Table 98. LeMaitre Vascular Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. LeMaitre Vascular Artificial Blood Vessel Product Portfolio Table 100. LeMaitre Vascular Recent Development Table 101. Suokang Company Information Table 102. Suokang Business Overview Table 103. Suokang Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Suokang Artificial Blood Vessel Product Portfolio Table 105. Suokang Recent Development Table 106. Chest Medical Company Information Table 107. Chest Medical Business Overview Table 108. Chest Medical Artificial Blood Vessel Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Chest Medical Artificial Blood Vessel Product Portfolio Table 110. Chest Medical Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Artificial Blood Vessel Distributors List Table 114. Artificial Blood Vessel Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Artificial Blood Vessel Product Image Figure 2. Global Artificial Blood Vessel Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Blood Vessel Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artificial Blood Vessel Sales (2021-2032) & (K Units) Figure 5. Global Artificial Blood Vessel Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Artificial Blood Vessel Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. EPTFE Image Figure 10. Polyethylene Terephthalate Image Figure 11. Polyurethane Image Figure 12. Others Image Figure 13. Global Artificial Blood Vessel Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Artificial Blood Vessel Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Artificial Blood Vessel Sales Volume Share by Type (2021-2032) Figure 16. Global Artificial Blood Vessel Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Artificial Blood Vessel Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Artificial Blood Vessel Sales Value Share by Type (2021-2032) Figure 19. Aortic Disease Image Figure 20. Peripheral Artery Disease Image Figure 21. Hemodialysis Image Figure 22. Global Artificial Blood Vessel Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Artificial Blood Vessel Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Artificial Blood Vessel Sales Volume Share by Application (2021-2032) Figure 25. Global Artificial Blood Vessel Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Artificial Blood Vessel Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Artificial Blood Vessel Sales Value Share by Application (2021-2032) Figure 28. Global Artificial Blood Vessel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Artificial Blood Vessel Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Artificial Blood Vessel Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Artificial Blood Vessel Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Artificial Blood Vessel Sales Value (2021-2032) & (US$ Million) Figure 33. North America Artificial Blood Vessel Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Artificial Blood Vessel Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Artificial Blood Vessel Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Artificial Blood Vessel Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Artificial Blood Vessel Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Artificial Blood Vessel Sales Value (2021-2032) & (US$ Million) Figure 39. South America Artificial Blood Vessel Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Artificial Blood Vessel Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Artificial Blood Vessel Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Artificial Blood Vessel Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Artificial Blood Vessel Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Artificial Blood Vessel Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • EPTFE
  • Polyethylene Terephthalate
  • Polyurethane
  • Others
Applications
  • Aortic Disease
  • Peripheral Artery Disease
  • Hemodialysis
Companies covered
  • Getinge
  • BD (Bard)
  • Terumo
  • W. L. Gore
  • Japan Lifeline
  • B.Braun
  • LeMaitre Vascular
  • Suokang
  • Chest Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artificial Blood Vessel Sales Value (2021-2032)
  4. 1.2.2 Global Artificial Blood Vessel Sales Volume (2021-2032)
  5. 1.2.3 Global Artificial Blood Vessel Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artificial Blood Vessel Market Dynamics
  1. 2.1 Artificial Blood Vessel Industry Trends
  2. 2.2 Artificial Blood Vessel Industry Drivers
  3. 2.3 Artificial Blood Vessel Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Vessel Industry Restraints
3 Artificial Blood Vessel Market by Company
  1. 3.1 Global Artificial Blood Vessel Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Blood Vessel Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Blood Vessel Sales Volume by Company (2021-2026)
  4. 3.4 Global Artificial Blood Vessel Average Price by Company (2021-2026)
  5. 3.5 Global Artificial Blood Vessel Company Ranking (2024-2026)
  6. 3.6 Global Artificial Blood Vessel Company Manufacturing Base and Headquarters
  7. 3.7 Global Artificial Blood Vessel Company Product Type and Application
  8. 3.8 Global Artificial Blood Vessel Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artificial Blood Vessel Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artificial Blood Vessel Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artificial Blood Vessel Market by Type
  1. 4.1 Artificial Blood Vessel Type Introduction
  2. 4.1.1 EPTFE
  3. 4.1.2 Polyethylene Terephthalate
  4. 4.1.3 Polyurethane
  5. 4.1.4 Others
  6. 4.2 Global Artificial Blood Vessel Sales Volume by Type
  7. 4.2.1 Global Artificial Blood Vessel Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Artificial Blood Vessel Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Artificial Blood Vessel Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Artificial Blood Vessel Sales Value by Type
  11. 4.3.1 Global Artificial Blood Vessel Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Artificial Blood Vessel Sales Value by Type (2021-2032)
  13. 4.3.3 Global Artificial Blood Vessel Sales Value Share by Type (2021-2032)
5 Artificial Blood Vessel Market by Application
  1. 5.1 Artificial Blood Vessel Application Introduction
  2. 5.1.1 Aortic Disease
  3. 5.1.2 Peripheral Artery Disease
  4. 5.1.3 Hemodialysis
  5. 5.2 Global Artificial Blood Vessel Sales Volume by Application
  6. 5.2.1 Global Artificial Blood Vessel Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artificial Blood Vessel Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Artificial Blood Vessel Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Artificial Blood Vessel Sales Value by Application
  10. 5.3.1 Global Artificial Blood Vessel Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Artificial Blood Vessel Sales Value by Application (2021-2032)
  12. 5.3.3 Global Artificial Blood Vessel Sales Value Share by Application (2021-2032)
6 Artificial Blood Vessel Regional Sales and Value Analysis
  1. 6.1 Global Artificial Blood Vessel Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Blood Vessel Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Blood Vessel Sales by Region: 2021-2026
  4. 6.2.2 Global Artificial Blood Vessel Sales by Region (2027-2032)
  5. 6.3 Global Artificial Blood Vessel Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artificial Blood Vessel Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artificial Blood Vessel Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artificial Blood Vessel Sales Value by Region (2027-2032)
  9. 6.5 Global Artificial Blood Vessel Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artificial Blood Vessel Sales Value (2021-2032)
  12. 6.6.2 North America Artificial Blood Vessel Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artificial Blood Vessel Sales Value (2021-2032)
  15. 6.7.2 Europe Artificial Blood Vessel Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artificial Blood Vessel Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artificial Blood Vessel Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artificial Blood Vessel Sales Value (2021-2032)
  21. 6.9.2 South America Artificial Blood Vessel Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artificial Blood Vessel Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artificial Blood Vessel Sales Value Share by Country, 2025 VS 2032
7 Artificial Blood Vessel Country-level Sales and Value Analysis
  1. 7.1 Global Artificial Blood Vessel Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Blood Vessel Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artificial Blood Vessel Sales by Country (2021-2032)
  4. 7.3.1 Global Artificial Blood Vessel Sales by Country (2021-2026)
  5. 7.3.2 Global Artificial Blood Vessel Sales by Country (2027-2032)
  6. 7.4 Global Artificial Blood Vessel Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artificial Blood Vessel Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artificial Blood Vessel Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artificial Blood Vessel Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artificial Blood Vessel Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artificial Blood Vessel Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Getinge
  2. 8.1.1 Getinge Company Information
  3. 8.1.2 Getinge Business Overview
  4. 8.1.3 Getinge Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Getinge Artificial Blood Vessel Product Portfolio
  6. 8.1.5 Getinge Recent Developments
  7. 8.2 BD (Bard)
  8. 8.2.1 BD (Bard) Company Information
  9. 8.2.2 BD (Bard) Business Overview
  10. 8.2.3 BD (Bard) Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BD (Bard) Artificial Blood Vessel Product Portfolio
  12. 8.2.5 BD (Bard) Recent Developments
  13. 8.3 Terumo
  14. 8.3.1 Terumo Company Information
  15. 8.3.2 Terumo Business Overview
  16. 8.3.3 Terumo Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Artificial Blood Vessel Product Portfolio
  18. 8.3.5 Terumo Recent Developments
  19. 8.4 W. L. Gore
  20. 8.4.1 W. L. Gore Company Information
  21. 8.4.2 W. L. Gore Business Overview
  22. 8.4.3 W. L. Gore Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 W. L. Gore Artificial Blood Vessel Product Portfolio
  24. 8.4.5 W. L. Gore Recent Developments
  25. 8.5 Japan Lifeline
  26. 8.5.1 Japan Lifeline Company Information
  27. 8.5.2 Japan Lifeline Business Overview
  28. 8.5.3 Japan Lifeline Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Japan Lifeline Artificial Blood Vessel Product Portfolio
  30. 8.5.5 Japan Lifeline Recent Developments
  31. 8.6 B.Braun
  32. 8.6.1 B.Braun Company Information
  33. 8.6.2 B.Braun Business Overview
  34. 8.6.3 B.Braun Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B.Braun Artificial Blood Vessel Product Portfolio
  36. 8.6.5 B.Braun Recent Developments
  37. 8.7 LeMaitre Vascular
  38. 8.7.1 LeMaitre Vascular Company Information
  39. 8.7.2 LeMaitre Vascular Business Overview
  40. 8.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LeMaitre Vascular Artificial Blood Vessel Product Portfolio
  42. 8.7.5 LeMaitre Vascular Recent Developments
  43. 8.8 Suokang
  44. 8.8.1 Suokang Company Information
  45. 8.8.2 Suokang Business Overview
  46. 8.8.3 Suokang Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Suokang Artificial Blood Vessel Product Portfolio
  48. 8.8.5 Suokang Recent Developments
  49. 8.9 Chest Medical
  50. 8.9.1 Chest Medical Company Information
  51. 8.9.2 Chest Medical Business Overview
  52. 8.9.3 Chest Medical Artificial Blood Vessel Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chest Medical Artificial Blood Vessel Product Portfolio
  54. 8.9.5 Chest Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Blood Vessel Value Chain Analysis
  2. 9.1.1 Artificial Blood Vessel Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Blood Vessel Sales Mode & Process
  6. 9.2 Artificial Blood Vessel Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Blood Vessel Distributors
  9. 9.2.3 Artificial Blood Vessel Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst